Cabaletta Bio Stock Analysis

CABA Stock  USD 16.02  0.03  0.19%   
The main objective of Cabaletta Bio stock analysis is to determine its intrinsic value, which is an estimate of what Cabaletta Bio is worth, separate from its market price. There are two main types of Cabaletta Bio's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Cabaletta Bio's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Cabaletta Bio's stock to identify patterns and trends that may indicate its future price movements.
The Cabaletta Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Cabaletta Bio is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Cabaletta Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Cabaletta Bio's ongoing operational relationships across important fundamental and technical indicators.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.

Cabaletta Stock Analysis Notes

About 72.0% of the company shares are held by institutions such as insurance companies. The book value of Cabaletta Bio was currently reported as 3.86. The company recorded a loss per share of 1.7. Cabaletta Bio had not issued any dividends in recent years. Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Cabaletta Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 57 people. For more info on Cabaletta Bio please contact the company at 267 759-3100 or go to

Cabaletta Bio Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Cabaletta Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Cabaletta Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Cabaletta Bio had very high historical volatility over the last 90 days
Net Loss for the year was (52.98 M) with profit before overhead, payroll, taxes, and interest of 0.
Cabaletta Bio currently holds about 96.81 M in cash with (46.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34.
Cabaletta Bio has a poor financial position based on the latest SEC disclosures
Roughly 72.0% of the company shares are held by institutions such as insurance companies
Latest headline from Is Cabaletta Bio Inc Stock at the Top of the Biotechnology Industry - InvestorsObserver

Cabaletta Bio Upcoming and Recent Events

Earnings reports are used by Cabaletta Bio to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cabaletta Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
21st of March 2024
Upcoming Quarterly Report
9th of May 2024
Next Financial Report
31st of December 2023
Next Fiscal Quarter End
21st of March 2024
Next Fiscal Year End
30th of September 2023
Last Quarter Report
31st of December 2022
Last Financial Announcement

Cabaletta Largest EPS Surprises

Earnings surprises can significantly impact Cabaletta Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Cabaletta Bio SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Cabaletta Bio prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Cabaletta Bio investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Cabaletta Bio specific information freely available to individual and institutional investors to make a timely investment decision.
9th of November 2023
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
6th of November 2023
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
2nd of October 2023
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
5th of September 2023
Financial Statements and Exhibits. Regulation FD Disclosure
22nd of August 2023
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
10th of August 2023
Financial Statements and Exhibits. Results of Operations and Financial Condition
24th of July 2023
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
1st of June 2023
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Unclassified Corporate Event

Cabaletta Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Cabaletta Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cabaletta Bio backward and forwards among themselves. Cabaletta Bio's institutional investor refers to the entity that pools money to purchase Cabaletta Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Last TransactionTypeSharesValue
Fred Alger Management Llc2023-09-30Common Shares4.3 M64.8 M
Adage Capital Partners Gp Llc2023-09-30Common Shares3.3 M49.7 M
Cormorant Asset Management Lp2023-09-30Common Shares2.9 M43.8 M
Commodore Capital Lp2023-09-30Common Shares2.5 M38.4 M
Blackrock Inc2023-09-30Common Shares2.4 M37.2 M
Deerfield Management Company Lp Series C2023-09-30Common Shares2.3 M35.6 M
Lynx1 Capital Management Lp2023-09-30Common Shares2.1 M32.1 M
Bain Capital Life Sciences Investors Llc2023-09-30Common SharesM30.4 M
Vr Adviser Llc2023-09-30Common SharesM30 M
Vanguard Group Inc2023-09-30Common SharesM30 M
Redmile Group Llc2023-09-30Common Shares1.8 M27 M
Note, although Cabaletta Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Cabaletta Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 686.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cabaletta Bio's market, we take the total number of its shares issued and multiply it by Cabaletta Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Cabaletta Profitablity

Cabaletta Bio's profitability indicators refer to fundamental financial ratios that showcase Cabaletta Bio's ability to generate income relative to its revenue or operating costs. If, let's say, Cabaletta Bio is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Cabaletta Bio's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Cabaletta Bio's profitability requires more research than a typical breakdown of Cabaletta Bio's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2023
Return on Average Assets(0.50)(0.54)
Return on Average Equity(0.54)(0.55)
Return on Invested Capital(1.40)(1.44)

Management Efficiency

Cabaletta Bio has return on total asset (ROA) of (0.3199) % which means that it has lost $0.3199 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5063) %, meaning that it created substantial loss on money invested by shareholders. Cabaletta Bio's management efficiency ratios could be used to measure how well Cabaletta Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of December 3, 2023, Return on Average Assets is expected to decline to -0.54. In addition to that, Return on Average Equity is expected to decline to -0.55. At present, Cabaletta Bio's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Current Assets is expected to grow to about 117.7 M, whereas Return on Average Assets are forecasted to decline to (0.54).
Last ReportedProjected for 2023
Book Value per Share 3.60  3.29 
Enterprise Value over EBIT(4.60)(4.96)
Enterprise Value over EBITDA(4.20)(4.53)
Price to Book Value 2.57  2.26 
Tangible Assets Book Value per Share 4.03  5.35 
Enterprise Value207.2 M177.7 M
Tangible Asset Value117 M123.4 M
The analysis of Cabaletta Bio's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Cabaletta Bio's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Cabaletta Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.

Technical Drivers

As of the 3rd of December, Cabaletta Bio shows the risk adjusted performance of 0.0552, and Mean Deviation of 3.97. Cabaletta Bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed nineteen technical drivers for Cabaletta Bio, which can be compared to its rivals. Please confirm Cabaletta Bio mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and information ratio to decide if Cabaletta Bio is priced correctly, providing market reflects its regular price of 16.02 per share. Given that Cabaletta Bio has jensen alpha of 0.3371, we suggest you to validate Cabaletta Bio's prevailing market performance to make sure the company can sustain itself at a future point.

Cabaletta Bio Price Movement Analysis

Execute Study
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Cabaletta Bio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Cabaletta Bio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Cabaletta Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cabaletta Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cabaletta Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cabaletta Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Cabaletta Bio Technical and Predictive Indicators

Cabaletta Bio Forecast Models

Cabaletta Bio's time-series forecasting models are one of many Cabaletta Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cabaletta Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Cabaletta Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cabaletta Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cabaletta shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cabaletta Bio. By using and applying Cabaletta Stock analysis, traders can create a robust methodology for identifying Cabaletta entry and exit points for their positions.
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Cabaletta Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 57 people.

Current Cabaletta Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cabaletta analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cabaletta analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
32.0Strong Buy7Odds
Cabaletta Bio current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Cabaletta analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cabaletta stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cabaletta Bio, talking to its executives and customers, or listening to Cabaletta conference calls.
Cabaletta Analyst Advice Details

Cabaletta Stock Analysis Indicators

Cabaletta Bio stock analysis indicators help investors evaluate how Cabaletta Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cabaletta Bio shares will generate the highest return on investment. By understating and applying Cabaletta Bio stock analysis, traders can identify Cabaletta Bio position entry and exit signals to maximize returns.
Begin Period Cash Flow122.2 M
Common Stock Shares Outstanding21.5 M
Total Stockholder Equity104.5 M
Total Cashflows From Investing Activities-27.2 M
Property Plant And Equipment Net7.6 M
Cash And Short Term Investments106.5 M
Cash81.6 M
Accounts Payable2.5 M
Net Debt-76.5 M
50 Day M A15.5035
Total Current Liabilities9.5 M
Other Operating Expenses54.1 M
Non Current Assets Total8.1 M
Non Currrent Assets Other565 K
Stock Based Compensation6.9 M
When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.
Note that the Cabaletta Bio information on this page should be used as a complementary analysis to other Cabaletta Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Cabaletta Stock analysis

When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Valuation
Check real value of public entities based on technical and fundamental data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Transaction History
View history of all your transactions and understand their impact on performance
Is Cabaletta Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Return On Assets
Return On Equity
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.